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Background. Within the developing world, many personal, sociocultural, and economic factors cause delayed patient presentation,
a prolonged interval from initial symptom discovery to provider presentation. Understanding these barriers to care is crucial to
optimizing interventions that pre-empt patient delay. Methods. A systematic review was conducted querying: PubMed, Embase,
Web of Science, CINAHL, Cochrane Library, J East, CAB, African Index Medicus, and LiLACS. Of 763 unique abstracts, 122
were extracted for full review and 13 included in ﬁnal analysis. Results. Studies posed variable risks of bias and produced mixed
results. There is strong evidence that lower education level and lesser income status contribute to patient delay. There is weaker
and, sometimes, contradictory evidence that other factors may also contribute. Discussion. Poverty emerges as the underlying
common denominator preventing earlier presentation in these settings. The evidence for sociocultural variables is less strong,
but may reﬂect current paucity of high-quality research. Conﬂicting results may be due to heterogeneity of the developing world
itself. Conclusion. Future research is required that includes patients with and without delay, utilizes a validated questionnaire, and
controlsforpotentialconfounders.Currentevidencesuggeststhatinterventionsshouldprimarilyincreaseproximalandaﬀordable
healthcare access and secondarily enhance breast cancer awareness, to productively reduce patient delay.
1.Introduction
Breast cancer remains the most common cancer and most
common cause of cancer-related mortality among women
worldwide [1]. While incidence rates have historically been
higher in the developed world, there has been a recent
sharp increase in incidence and mortality in the developing
world [2]. Furthermore, the case-fatality rate (or relative
survival, approximated as the compliment of the mortality
to incidence ratio [3]) within these nations tends to be lower,
largely due to patients presenting at more advanced stages
[2].
Delayed patient presentation refers to a prolonged inter-
val between discovery of initial symptom to presentation
to a provider and is typically deﬁned as greater than 12
weeks, as periods longer than this have been associated
with poorer survival [4]. In contrast, provider delay refers
to an extended interval from initial patient presentation to
eﬀective oncological treatment. Nonetheless, providers and
healthsystemsmayserveasprimarysourcesofhealth-related
education and aﬀect patient delay as well. Patient delay has
been associated with increased tumor size, more advanced
stage at presentation, and poorer long-term survival [5]
and is a signiﬁcant concern in developing countries. For
example, one study in sub-Saharan Africa found that 90%
of breast cancer patients presented with stage III or IV
disease, exhibited a median primary tumor size of 10cm,
and displayed clinically palpable nodal disease [6] ,ap a t -
tern of disease so advanced that even optimal Western
therapy would oﬀer minimal survival value. As a result,
future interventions aimed at controlling the increase in
global breast cancer burden should address delayed patient
presentation in addition to extending access to advanced
care.2 Journal of Oncology
Table 1: Potential barriers-to-care causing delayed patient presentation.
Personal Sociocultural Economic
Age
Ethnicity
Marriage status
Clinical presentation
Personal history
Family history
Breast cancer awareness: knowledge of symptoms, breast self-exam (BSE) use
Alternative treatment use: other practitioners, prayer, herbal remedy
Fear of examination, treatment
Stigma of disease
Denial/anxiety
Overall level of social support
High cost of medical care
High cost of travel to clinic
Obligations at home/work
Access to health systems
Location of origin
Education level
Income status
Table 2: PICOTTS eligibility criteria for studies included in review.
Inclusion Exclusion
Population Female patients with breast cancer living within
developing countries.
Males, benign breast disease, living in the developed
world.
Intervention
A questionnaire inquiring about personal,
sociocultural, and economic variables that may have
contributed to delayed patient presentation.
Any study that did not explicitly deﬁne potential
variables contributing to patient delay, or did not apply
questionnaire consistently to every patient.
Control Patients who presented without delay, but not required. None.
Outcome
A deﬁnition of patient delayed presentation or an
interval >12 weeks between discovery of ﬁrst symptom
to presentation to a provider.
Any study that did not include its own deﬁnition of
patient delay, did not report a symptom-presentation
interval, or examined provider delay only.
Time (intervention) Any study conducted after 1990. Any study conducted before 1990.
Time (follow-up) No follow-up period required None.
Study design Case series, cross-sectional, or case-control, with a
sample size of at least n = 10.
Single case report, cohort study,
randomized-controlled trial, expert consensus and/or
other review, any sample size of n<10.
Numerous factors may result in delayed patient pre-
sentation and can be conceptually organized into three
potentially overlapping categories: personal, sociocultural,
and economic (Table 1); an understanding of these factors
is crucial to optimizing future interventions that preempt
patient delay. Existing research on this topic has mostly
focused on the developed world: one systematic review of
19 such studies concluded there was strong evidence for
older age and moderate evidence for not attributing initial
symptom to breast cancer, not disclosing breast symptoms to
another, discovering an initial symptom other than a lump,
nonwhite ethnicity, and fewer years of education [4].
Unfortunately, similar research focusing on developing
countries is more limited. As there may exist substantial
geographical variation in barriers to care due to diﬀering
social, cultural, and economic contexts—especially between
richer developed countries and poorer developing ones—
ﬁndings from developed countries cannot be generalized
to developing ones. To our knowledge, a systematic review
of barriers to care resulting in patient delay of breast
cancer within developing nations has not been performed.
Therefore, the purpose of this study is to (1) systematically
review the current available research examining personal,
sociocultural, and economic variables that may result in
delayedpatientpresentationwithindevelopingcountriesand
(2) highlight areas of deﬁciency requiring further research
such that subsequent interventions may be streamlined and
personalized according to the developing country’s context
of need.
2.MaterialsandMethods
This systematic review was modeled on the PRISMA guide-
lines [7]. Database inquiry was initiated into PubMed using
the Mesh headings “Patient Acceptance of Health Care”,
“Delayed Diagnosis”, and “Breast Neoplasms” with a text
search of “delay” or “late” in titles and abstracts. This search
was expanded and modiﬁed into the following additional
databases: Embase, Web of Science, CINAHL, Cochrane
Library, J East, CAB, African Index Medicus, and LiLACS.
Additional relevant studies were identiﬁed by manually
examining bibliographies of included articles and querying
content experts.
All studies required approval by Institutional Review
Boards (IRBs). Cross-sectional studies, case series, and case-
control analyses were acceptable for inclusion (Table 2).
Studies had to include a deﬁnition of delayed patient
presentation or report the interval between initial symptom
and presentation, deﬁne potential barriers to care, and
statisticallyassociatehowputativevariablescorrelatetodelay
orthatinterval.Theprimaryoutcomeofinterestwasdelayed
patient presentation; for studies without their own deﬁni-
tion, delay was deﬁned as symptom to presentation interval
>12 weeks. Furthermore, studies had to be conducted inJournal of Oncology 3
763 unique abstracts 
171 PubMed 
238 Embase 
90 CINAHL 
6 Cochrane Library 
0 African Index Medicus  
118 Web of Science 
309 CAB 
1 J-East 
2 LiLACS 
−172 duplicates
122 full texts extracted 
for in-depth review
13 articles met ﬁnal  
inclusion/exclusion criteria
641 abstracts excluded 
109 excluded 
66 in developing world 
19 theoretical 
16 not statistical
8 reviews 
Figure 1: Study selection ﬂowchart.
developing countries, deﬁned as a low- or middle-, income
economy by the World Bank based on per capita GNI [8].
To maintain contemporary relevance, only papers published
after 1990 were included.
Exclusion criteria were as follows: studies that did not
occur within developing countries, occurred before 1990,
did not explicitly state what barriers to care were inquired
about in their questionnaire/survey, did not consistently
apply the same questionnaire/survey to every patient, did
not include a speciﬁc deﬁnition of delayed patient presenta-
tion and/or did not report symptom-presentation interval,
investigated sources of provider delay only, consisted of
cohort studies, randomized-controlled trials (RCTs), expert
consensus/opinion, or other reviews, had a sample size of
n<10, or included only males or patients with benign breast
pathology.
Authors Sharma and Costas independently reviewed
abstracts and (if necessary) full articles to determine inclu-
sion eligibility, with disagreements resolved by discussion.
Sharma abstracted study information into tables, with both
checking information for accuracy. Sharma and Costas
independently assessed study quality and then compared
results, with disagreements resolved by discussion.
Quality was graded using criteria adapted from the
United States Preventive Services Task Force (USPSTF).
For each study, Sharma and Costas graded selection bias,
measurement bias, and confounding potential as good (G),
fair (F), or poor (P). Ratings were converted into numerical
valuesasfollows:G = 2,F = 1,andP = 0.Then,acomposite
score evaluating each study’s overall risk of bias (internal
validity) was averaged from these components, with 1.5 or
h i g h e rc o n s i d e r e dg o o d( G ) ,1 . 0t o1 . 4 9c o n s i d e r e df a i r( F ) ,
and less than 1.0 considered poor (P). Finally, each study’s
external validity was evaluated.
Afterdataabstractionandqualityassessment,thisstudy’s
authors met for discussion about results and continued
iterative review until reaching consensus about key message
and conclusions. No meta-analyses could be performed
due to heterogeneity of study populations, diﬀerences in
inquiry regarding speciﬁc barriers to care, and diﬀerences in
deﬁnition of delayed presentation.
3. Results
3.1. Search Results. Overall, 13 articles were included in
ﬁnal analysis, all identiﬁed via primary literature search
(Figure 1).
Included studies occurred in the following developing
countries: Aziz et al. [9] and Malik et al. [10] in Pakistan,
Ezeome [11] and Ukwenya et al. [12] in Nigeria, Harirchi et
al. [13] and Montazeri et al. [14] in Iran, Abdel-Fattah et al.
[15]i nE g y p t ,A l ie ta l .[ 16] in India, Clegg-Lamptey et al.
[17] in Ghana, Landolsi et al. [18] in Tunisia, Norsa’adah
et al. [19] in Malaysia, Pi˜ neros et al. [20] in Colombia, and
Thongsuksai et al. [21] in Thailand. 11 of the 13 were cross-
sectional analyses, whereas 2 were case series examining
patients with delay only (Table 3).
3.2. Selection Bias. E i g h ts t u d i e sw e r er a t e d“ G o o d ”o rp o s e d
low potential for selection bias: Abdel-Fattah et al. [15],4 Journal of Oncology
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Table 4: Qualitative synthesis of barriers-to-care utilizing good and fair studies.
Evidence strength
Barriers-to-care
Personal Sociocultural Economic
Good (strong) Unmarried, widowed, or divorced Lower income status
Positive family history Lower education level
Fair (moderate)
Older age
Married
Negative family history
Clinical presentation: ulcer, lack of pain,
palpable axillary lymph nodes
Alternative treatment use: other
practitioners, prayer
Breast cancer awareness: failure to
practice BSE, ignorance of symptoms as
cancer
Fear of treatment
Rural residency
Health systems: lack of aﬃliation,
lesser access to physicians
Ali et al. [16], Ezeome [11], Harirchi et al. [13], Landolsi
et al. [18], Montazeri et al. [14], Norsa’adah et al. [19],
and Pi˜ neros et al. [20]. These were relatively high-powered,
recruited from one or more high-volume centers, and
includedawidearrayofpatientswithvaryingdemographics.
Four studies were rated “Fair” or posed moderate
potential for selection bias. Aziz et al. [9]w a sr e l a t i v e l y
high-powered (n = 286) but did not report pertinent
demographic data. Malik et al. [10]( n = 103), Thongsuksai
et al. [21]( n = 94), and Ukwenya et al. [12]( n = 99)
reported demographic data but had medium-sized samples.
The remaining study, Clegg-Lamptey et al. [17], was rated
“Poor” for selection bias potential as it was relatively low-
powered (n = 66).
3.3. Measurement Bias. All 13 studies utilized standardized
questionnaires applied consistently to each patient. In some
cases, these questionnaires were validated by independent
e x p e r t sa n dt e s t e di nf o c u sg r o u p s .T h e s ep r o c e d u r e sr e d u c e
the potential for measurement bias. However, all studies
assessed delay retrospectively, as patients were asked to
remember the time interval from ﬁrst symptom to pre-
sentation, introducing potential recall bias. In fact, there is
evidence that patients may underreport duration of delay
[22]. But this bias is acceptable and unavoidable, as delay
must be assessed retrospectively for ethical reasons. Thus,
twelve of the studies were evaluated as “Fair” or introducing
moderate potential for measurement bias.
The remaining study, Norsa’adah et al. [19], was eval-
uated as “Poor” or introducing high potential for mea-
surement bias, as they reported an outcome of “diagnosis
delay” that combined patient and provider delay, deﬁned as
greater than 6 months from initial symptom to pathological
diagnosis. Thus, potential barriers to care may be aﬀecting
provider delay as well, with independent eﬀect on patient
delay alone being less observable.
3.4. Confounding Potential. An independent estimate of how
a potential barrier-to-care may delay patient presentation
requires controlling for confounding, including other poten-
tial barriers to care and patient demographic data. Since it is
unethical to randomize patients to potential barriers to care
andthenprospectivelyassesstheirdelay,statisticallyrigorous
multivariate regression is required for eﬀective covariate
control.
Four of the studies were evaluated as “Good” as they
included numerous covariates into such a regression model:
Ali et al. [16], Montazeri et al. [14], Norsa’adah et al. [19],
and Thongsuksai et al. [21]. Another study was evaluated as
“Fair” as it introduced moderate potential for confounding:
Abdel-Fattah et al. [15] utilized multivariate regression but
controlled for only age and education status, two of many
potential confounders. The remaining eight studies were all
evaluated as “Poor” as they employed univariate analyses
only.
3.5. Overall Risk of Bias/Internal Validity. Ultimately, two
studies were classiﬁed as “Good” for posing low overall
risk of bias: Ali et al. [16] in India and Montazeri et al.
[14] in Iran. Both employed large sample sizes, included a
varietyofpatientswithdiﬀerentdemographics,utilizedstan-
dardized questionnaires, and controlled for many potential
confounders via multivariate regression.
Another seven studies were classiﬁed as “Fair” or posed
moderate overall risk of bias: Abdel-Fattah et al. [15],
Ezeome [11], Harirchi et al. [13], Landolsi et al. [18],
Norsa’adah et al. [19], Pi˜ neros et al. [20], and Thongsuksai
et al. [21]. These studies contribute meaningful information
by highlighting certain barriers to care as potentially causing
patient delay. Nonetheless, their observed results should be
interpreted with some caution.
The remaining four studies posed high overall risks of
bias and were classiﬁed as “Poor”: Aziz et al. [9], Clegg-
Lamptey et al. [17], Malik et al. [10], and Ukwenya et al.
[12]. These studies involved low or medium sample sizes
and did not attempt to control for confounders. Thus, any
barriers to care found to be signiﬁcant via these studies must
be interpreted with caution, especially if they did not exhibit
signiﬁcance via the “Good” or “Fair” studies.
3.6. Qualitative Synthesis. A qualitative synthesis utilizing
only the “Good” and “Fair” studies is provided in Table 4.
Results from “Good” studies are listed as exhibiting good or
strong evidence and “Fair” studies as exhibiting far or mod-
erate evidence. Furthermore, barriers to care are classiﬁed
into a personal, sociocultural, or economic schematic.6 Journal of Oncology
Overall, studies rated as “Good” showed evidence that
positive family history of breast cancer, lower education
level, lower income status, and being unmarried/ divorced/
widowed contributes to delayed patient presentation.
Studies rated as “Fair” showed evidence for a number of
barriers to care. In terms of personal characteristics, older
age, marriage, negative family history of breast cancer, and
clinical presentation speciﬁcs (namely, presence of breast
ulcer, lack of pain, and presence of palpable axillary lymph
nodes) are moderately linked to patient delay. In terms of
sociocultural context, alternative treatment use (including
use of other practitioners and use of prayer), breast cancer
awareness (including failure to practice breast self-exam and
ignorance of initial symptoms as relating to cancer), and fear
of treatment are moderately linked to patient delay. In terms
of economic variables, rural residency and health systems
context(especiallylack of aﬃliation with a health systemand
lower access to physicians) are moderately linked to patient
delay.
Notably, diﬀerent studies yielded diﬀerent and, some-
times, contradictory results. For example, one study found
an association between being married and patient delay,
while another observed an association between not being
married and patient delay. In addition, one study found a
positive correlation between family history and patient delay,
while another observed a negative correlation instead.
4. Discussion
Delay is a major contributor to advanced-stage presentation
of breast cancer [22], the predominant cause of poorer sur-
vival within the developing world [23]. Delayed presentation
can be divided into two sequential components: patient
delay,aprolongedintervalfromdiscoveryofinitialsymptom
to presentation to a qualiﬁed medical provider, and provider
delay, a prolonged interval from patient presentation to ﬁrst
oncologic treatment. This systematic review evaluated the
current research investigating potential personal, sociocul-
tural, and economic barriers to care that may cause patient
delay within the developing world (Table 1).
The predominant theme emerging from the results of
this review emphasizes how poverty constitutes the under-
lying common denominator and most important barrier
contributingtodelayedpatientpresentationinthesesettings.
These conditions of poverty are supported by evidence from
both “Good” and “Fair” studies and chieﬂy manifested
economically via lower income status, lesser education level,
rural residency, and lack of access to healthcare systems
(Table 4). This may reﬂect how these low-income developing
countries “share an economic status” where “the infrastruc-
ture and human resources for cancer prevention or control
are nonexistent or very limited in quantity, quality, and
accessibility [24].”
The association between the personal characteristics of
marital status and family history with patient delay showed
contradictory results from diﬀerent studies. As noted, two
studies associated being widowed or divorced with patient
delay [14, 16], whereas another reported increased delay
amongst married women [13]. In addition, one study
observed a positive correlation between family history of
breast cancer and patient delay [16], while another reported
a negative correlation [13]. These conﬂicting results may
be secondary to the varying risks of bias within the
studies (Table 2). However, they may also reﬂect geographic
variation in barriers to care due to the multidimensional
heterogeneity of the developing world, where societies,
cultures,andgovernmentsdiﬀertremendously. Asit remains
important not to generalize barriers to care from the
developed world over to the developing world, it remains
similarly prudent not to extrapolate from one part of the
developing world to another.
Importantly, all of the studies discovering a signiﬁcant
association between a sociocultural barrier-to-care and
patient delay were classiﬁed as either “Poor” or “Fair.”
This may imply that such variables are less inﬂuential,
more variable from site to site, and/or harder to elucidate
on investigation. However, neither of the “Good” studies
inquired about speciﬁc sociocultural variables pertaining to
breast cancer, such as stigma of disease, breast self-exam use,
and fear of treatment. Therefore, while the current evidence
for such sociocultural factors remains moderate, this may
reﬂect the current paucity of overall “Good” studies, and
future research is required to ascertain the true relationship
between sociocultural variables and patient delay in the
developing world.
Thisreview’sﬁndingsaresomewhatdiﬀerentthanaprior
reviewfocusingonpatientsinthedevelopedworld[4].Here,
Ramirez et al. concluded there was strong evidence that
patient delay was associated with older age and unrelated to
patient marital status, and there was moderate evidence that
patient delay was associated with fewer years of education,
nonwhite ethnicity, discovery of initial symptom other than
a breast lump, not disclosing breast symptoms to another,
and not attributing breast symptoms to cancer [4].
As stated, this review observed variable risks of bias
amongst included studies. Unfortunately, most studies were
of poor to fair internal validity, such that results must
be concluded with caution. The “Good” studies [14, 16]
followed several strategies which should serve as guidelines
for future investigations in this arena. First, selection bias
should be minimized by using either a high-powered cross-
sectional examination or a matched case-control analy-
sis, as a comparison between patients with and without
delay reveals causative factors that may result in delay.
Second, measurement bias in retrospective studies should
be minimized by utilizing a independentlyvalidated and
standardized questionnaire or survey, and by explicitly
deﬁning patient delay as separate from provider delay.
Third, confounding should be addressed via statistically
rigorous multivariate regression that controls for patient
demographics and other barriers to care.
This review does suﬀer from certain limitations. First,
while the search was thorough, involving 760+ initial
abstracts from 9 English and foreign databases, there is a
chance that other articles published in foreign languages
and/or foreign journals that are less accessible through largeJournal of Oncology 7
databases were missed. Second, the qualitative synthesis
incorporated only barriers to care that exhibited statistical
signiﬁcance in “Good” or “Fair” studies. This strategy
importantly accounts for study quality, but also prioritizes
statistical signiﬁcance in a “Fair” study over nonsigniﬁcance
in a “Good” study, largely due to the high burden to prove
statistical signiﬁcance. Furthermore, this strategy neglects
results from the “Poor” studies if they are not also corrobo-
rated by “Fair” or “Good” studies. While the “Poor” studies
certainly contribute valuable information in their respective
countries, they ultimately posed too high a risk of bias for
their results to be considered independent and reliable.
The results from this review should guide future
interventions that target patient delay within the developing
world. Speciﬁcally, since poverty appears to be the most
common and strongest barrier-to-care, future interventions
should primarily attempt to enhance access to proximate
and aﬀordable healthcare. Traveling away from home, family
and work responsibilities, and high cost of diagnosis and
treatment constitute particularly burdensome problems
facing the poor. In addition, while the evidence for
sociocultural barriers may be less strong as of now, future
interventions should also attempt to raise breast cancer
awareness and reduce stigma of disease, as secondary
objectives. Notably, causes of delay may also be hierarchical;
for instance, if poverty is successfully addressed, other
factors may play a more signiﬁcant role. This review
suggests that these tactics may productively pre-empt patient
delay and begin to control the burden of breast cancer
within the developing world, as long as interventions are
speciﬁcallytailored to the country of need.
5. Conclusion
Understanding the array of personal, sociocultural, and
economic barriers to care that contribute to delayed patient
presentation of breast cancer within developing countries
is crucial to controlling the disease globally. This systematic
review found strong evidence for personal and economic
factors relating to patient delay and moderate evidence for
sociocultural ones. Future research is required speciﬁcally to
developing countries and/or regions that is high-powered,
utilizes a standardized questionnaire, and controls for
potential confounders. Nonetheless, existing evidence
suggests that interventions targeting these barriers to care
should primarily extend access to aﬀordable and proximate
healthcare, and secondarily increase breast cancer awareness,
to productively reduce patient delay.
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